Condition: Metastatic Gastric Cancer · Gastric Cancer · Systemic Therapy · Sponsor: University Medical Center Ho Chi Minh City (UMC)
The results of the current studies to determine the optimal strategy for metastatic gastric cancer remain contrversial worldwide. Hypothesis: Cytoreductive Gastrectomy After Systemic Therapy will improve survival time for metastasis gastric cancer compared to Systemic Therapy alone.
This description comes directly from the study's public registry record.
Vo D Long, Prof. · +84918133915 · long.vd@umc.edu.vn
Nguyen V Hai, MD · hai.nv@umc.edu.vn
Always discuss trial participation with your own doctor first.
| University Medical Center | Ho Chi Minh City, Ho Chi Minh, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06768463